Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Therapy of progressive scleroderma with gamma-interferon].

¹Universitäts-Haut- und Poliklinik Hamburg-Eppendorf.

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete

|June 1, 1991

Summary

Gamma interferon treatment in progressive systemic sclerosis patients showed significant improvements in skin thickness and pain, halting disease progression. While internal organ effects were not observed, side effects were mild and transient.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodies.

The British journal of dermatology·2015

Same author

Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis.

The British journal of dermatology·2012

Same author

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.

The British journal of dermatology·2011

Same author

Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months data.

The British journal of dermatology·2009

Same author

Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies.

The British journal of dermatology·2009

Same author

Treatment with pimecrolimus cream 1% clears irritant dermatitis of the periocular region, face and neck.

International journal of dermatology·2008

Area of Science:

Immunology
Rheumatology
Dermatology

Context:

Progressive systemic sclerosis (PSS) is a chronic autoimmune disease characterized by fibrosis.
Current treatments for PSS have limited efficacy in halting disease progression.
Gamma interferon is a cytokine with immunomodulatory properties.

Purpose:

To evaluate the therapeutic effects of gamma interferon in patients with progressive systemic sclerosis.
To assess the impact of gamma interferon on skin thickness, pain, and internal organ function.
To determine the safety and tolerability of gamma interferon in PSS patients.

Summary:

An open study administered gamma interferon to 12 PSS patients over 6 months.
Significant improvements were observed in skin thickness (83%), muscle/joint pain (63%), and procollagen-type III peptide levels (66%).

Related Experiment Videos

No disease progression was noted, and side effects were mild and transient.

Impact:

Gamma interferon demonstrates potential as a treatment for progressive systemic sclerosis, particularly for skin and musculoskeletal manifestations.
The study suggests that gamma interferon may halt disease progression in PSS.
Further research is warranted to explore long-term efficacy and optimal dosing of gamma interferon in PSS.